Overview


According to FutureWise analysis the market for coronary stent in 2023 is US$ 9.43 billion, and is expected to reach US$ 12.44 billion by 2031 at a CAGR of 3.52%.

Expandable tubular metallic implants known as coronary stents (CS) are inserted inside coronary arteries with stenosis due to atherosclerosis. This revascularization procedure is referred to as percutaneous coronary intervention (PCI) or coronary angioplasty with stent placement (CASP). The shape, structure, and material composition of coronary stents have all altered since the 1980s when the first ones were developed. Prior to the development of stents, the mainstay of myocardial revascularization was balloon angioplasty, which involved inserting a catheter with an inflating balloon tip into the coronary arteries. The atherosclerotic plaque was crushed against the vascular wall, and blood flow to the heart was restored once the balloon was inflated once it had reached the coronaries. After deflating, the balloon was taken away. Abrupt arterial thrombosis, coronary artery dissection, abrupt vascular closure brought on by arterial recoil, and restenosis brought on by neointimal hyperplasia are only a few of the harmful side effects of this medication.

Coronary stents have abolished vascular recoil and coronary dissection by inhibiting negative remodelling and having an expandable metallic meshwork. A growing geriatric population, an increase in demand for minimally invasive procedures, an increase in the frequency of coronary artery disorders, and the development of new technologies pertinent to this industry are projected to drive the market for coronary stents.

FutureWise Market Research has published a report that provides an insightful analysis of Coronary Stent market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, the Coronary Stent market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Medtronic PLC
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Biosensors International Group, Ltd.
  • Biotronik SE & Co. Kg
  • B. Braun Melsungen AG
  • Terumo Corporation
  • Stentys SA
  • Microport Scientific Corporation
  • Meril Life Sciences Pvt. Ltd.
  • Vascular Concepts Limited
  • Translumina GmbH
  • Cook Medical
  • Elixir Medical Corporation

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Coronary Stent Market:

In May 2022-FDA approval was given to Medtronic plc for their Onyx Frontier drug-eluting stent, which has a delivery mechanism that improves the stent's acute performance and deliverability.

The rising frequency of coronary artery diseases (CADs), brought on by a build-up of plaque in the artery, necessitate the use of percutaneous coronary intervention therapies, including stents, is the main factor anticipated to propel expansion in the coronary stent market. The elderly population is more prone to various chronic diseases, including cardiovascular diseases (CVDs), which require surgical treatment since they can lead to plaque build-up in the arteries. Because of this, it is projected that the growing global geriatric population and CVDs would increase the requirement for stents in percutaneous coronary intervention procedures and drive market growth over the forecast period. Moreover, The increased desire for minimally invasive procedures (MIS) is another reason expected to enhance the use of coronary stents. These techniques involve little incision wounds that offer the advantage of raising patient satisfaction. These methods also decrease hospital stays and expedite recovery. Enhanced DES and the creation of bioresorbable scaffolds have increased the popularity of stenting technology relative to conventional balloon angioplasty. Thanks to technological advancements in coronary stents, such as the development of bifurcation stents and the use of biodegradable materials, the efficacy and outcomes of treating CVD have improved. Technology advancements in coronary stents, particularly the introduction of bifurcation stents and the use of biodegradable materials, have improved the efficacy and outcomes of treating CVD. The major of stents in chronic diseases is further propelling the market growth. However, despite the expanding need for therapeutic options, expansion may be somewhat constrained by the challenge of deploying coronary stents. Further impeding industry expansion would be strict government regulations on product licenses. A coronary stent might also result in infection. For instance, fever with various onsets and chest discomfort were CSI's most prevalent signs and symptoms. Surprisingly, the initial stent insertion frequently resulted in coronary stent infection (CSI). Additionally, drug-eluting stents carried a higher risk of infection than bare-metal stents.

By Type

  • Bare-metal Stents
  • Drug-eluting Stents
  • Bioabsorbable Stents

By Mode of Delivery

  • Balloon-expandable Stents
  • Self-expanding Stents

By Material

  • Metallic Stents
    •    Cobalt Chromium
    •    Platinum Chromium
    •    Nickel Titanium
    •    Stainless Steel
  • Other Stents

By End User

  • Hospitals
  • Cardiac Centers
  • Ambulatory Surgical Centers

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. The coronary stents market in North America is primarily driven by a sedentary lifestyle that causes obesity and other cardiovascular disorders like heart attack, stroke, ischaemic heart disease (IHD), etc. Technological developments in coronary stent technologies, such as drug-eluting stents and the utilization of biodegradable materials, have also accelerated market growth. The market expansion in this region is driven by established market players like Medtronic, Abbott, and Boston Scientific.

Additionally based on type; drug-eluting segment dominated the market in 2022. Drug-eluting stents (DES) provide an antiproliferative medication to the target lesion to stop excessive neointima growth. After the DES is implanted, the anti-restenotic medication is mixed into the polymer and released over weeks to months. DES is favored over bare-metal stents and other stent types for percutaneous coronary intervention with stenting because of their significantly lower risk of target vessel revascularization. This is anticipated to significantly contribute to the drug-eluting stent's expansion.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Coronary Stent Market By Type, By Mode of Delivery, By Material, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- Type launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to:sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders

  • 2.   Research Mode of Deliveryology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study

  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Coronary Stent Market Variables, Trends and Scope
    •        1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Coronary Stent Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Coronary Stent Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Coronary Stent Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Bare-metal Stents
        2. Drug-eluting Stents
        3. Bioabsorbable Stents

  • 8.   Coronary Stent Market, By Mode of Delivery Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Balloon-expandable Stents
        2. Self-expanding Stents

  • 9.   Coronary Stent Market, By Material Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Metallic Stents
         1.1. Cobalt Chromium
         1.2. Platinum Chromium
         1.3. Nickel Titanium
         1.4. Stainless Steel
        2. Other Stents

  • 10.   Coronary Stent Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Cardiac Centers
        3. Ambulatory Surgical Centers

  • 11.   North America Coronary Stent Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Coronary Stent Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Coronary Stent Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Coronary Stent Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Types Offered and Financial Layouts)
    •   1. Medtronic PLC
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Abbott Laboratories
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Boston Scientific Corporation
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Biosensors International Group, Ltd.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Biotronik SECo. Kg
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. B. Braun Melsungen AG
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Terumo Corporation
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Stentys SA
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Microport Scientific Corporation
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Meril Life Sciences Pvt. Ltd..
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Vascular Concepts Limited
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Translumina GmbH
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Cook Medical
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Elixir Medical Corporation
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients